Depression too often reduced to a checklist of symptoms

 

Leuven, BE (October 23, 2015) – How can you tell if someone is depressed? The Diagnostic and Statistical Manual of Mental Disorders (DSM) – the ‘bible’ of psychiatry – diagnoses depression when patients tick off a certain number of symptoms on the DSM checklist. A large-scale quantitative study coordinated at KU Leuven, Belgium, now shows that some symptoms play a much bigger role than others in driving depression, and that the symptoms listed in DSM may not be the most useful ones. 


To diagnose depression, psychiatrists typically tally up the number of depression symptoms that patients report in questionnaires. It does not matter which of the symptoms these patients have, as long as they have a certain number of them.

 

A new study challenges that approach. “We need to stop thinking of depression as a disease that causes a number of interchangeable symptoms”, says lead author Dr Eiko Fried from the KU Leuven Faculty of Psychology and Educational Sciences. “Depression is a complex, extremely heterogeneous system of interacting symptoms. And some of these symptoms may be far more important than others”.

 

The researchers analysed data on 28 symptoms provided by 3463 depressed patients. They then examined the connections between these symptoms. Their network analysis shows that some symptoms are more ‘central’ – more connected – than others. As a result, these symptoms have a much bigger impact on the depressive process.

 

We need to stop thinking of depression as a disease that causes a number of interchangeable symptoms. 

 

“If you think of depression as a network of interacting symptoms, one symptom can cause another”, Fried clarifies. “For instance, insomnia may lead to fatigue, which in turn may cause concentration problems that feed back into insomnia. This example of a vicious circle shows that the specific symptoms patients report, and their interactions, can be of crucial clinical importance”.

 

“Depression is not like, say, measles. When you have measles, your symptoms help the doctor figure out what underlying disease you have. But once you are diagnosed, it doesn’t really matter which of the possible symptoms you did or didn’t get. Treating the disease itself makes all your symptoms disappear. Depression is more complicated. It is not an infection or a specific brain disease. There is no easy cure, no drug that makes all symptoms go away. Instead, we may want to focus treatment efforts on the symptoms driving a patient’s depression”.

 

In the study, the two main DSM symptoms – sad mood and decreased interest or pleasure – ranked among the top 5 in terms of centrality. But the researchers also found that DSM symptoms such as hypersomnia, agitation, and weight change are not more central than other common depression symptoms such as pessimism and anxiety.

 

So where does that leave psychiatry? Has the time come to chuck the DSM checklist of depression symptoms? “Ideally, the list of depression symptoms should become more comprehensive to do justice to the heterogeneity of depression. I also think both clinicians and researchers can learn a lot from paying more attention to individual symptoms and their interactions. But of course, we need much more research before we can actually replace the DSM diagnosis of depression with something else”. 

 

Katrien Bollen

 

 

 


KU Leuven, 23.10.2015 (tB).

MEDICAL NEWS

New guidance to prevent the tragedy of unrecognized esophageal intubation
Overly restrictive salt intake may worsen outcomes for common form…
COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Scientists discover how salt in tumours could help diagnose and…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Kaltplasma bei diabetischem Fußsyndrom wirkt via Wachstumsfaktoren
Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…
Suliqua®: In komplexem Umfeld – einfach besser eingestellt
Suliqua®: Überlegene HbA1c-Senkung  im Vergleich zu Mischinsulinanalogon
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…

ERNÄHRUNG

Gesunde Ernährung: „Nicht das Salz und nicht das Fett verteufeln“
Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?

ONKOLOGIE

Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
Aktuelle Kongressdaten zum metastasierten Mammakarzinom und kolorektalen Karzinom sowie Neues…
Mehr Lebensqualität für onkologische Patient:innen durch bessere Versorgung: Supportivtherapie, Präzisionsonkologie,…
WHO veröffentlicht erste Klassifikation von Tumoren im Kindesalter
Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver

MULTIPLE SKLEROSE

Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…